Atıf İçin Kopyala
KAYASELCUK F., ZORLUDEMIR S., GUMURDULU D., ZEREN H., Erman T.
JOURNAL OF NEURO-ONCOLOGY, cilt.57, sa.2, ss.115-121, 2002 (SCI-Expanded)
-
Yayın Türü:
Makale / Tam Makale
-
Cilt numarası:
57
Sayı:
2
-
Basım Tarihi:
2002
-
Doi Numarası:
10.1023/a:1015739130208
-
Dergi Adı:
JOURNAL OF NEURO-ONCOLOGY
-
Derginin Tarandığı İndeksler:
Science Citation Index Expanded (SCI-EXPANDED), Scopus
-
Sayfa Sayıları:
ss.115-121
-
Anahtar Kelimeler:
central nervous system tumors, proliferative activity, grade, Ki-67, PCNA, CELL NUCLEAR ANTIGEN, BROMODEOXYURIDINE LABELING INDEX, MONOCLONAL-ANTIBODY KI-67, HUMAN-BRAIN TUMORS, PROGNOSTIC IMPLICATIONS, PROLIFERATIVE ACTIVITY, EXPRESSION, ASTROCYTOMAS, NEOPLASMS, CYCLE
-
Çukurova Üniversitesi Adresli:
Evet
Özet
Determination of proteins in the control of proliferation in normal cells helps a better understanding of cellular transformation and proliferation mechanisms. Measurement of proliferative activity is important in determining the tumor grade, recurrence span and malignancy. Proliferating cell nuclear antigen (PCNA) and Ki-67 are two of the nuclear markers used to demonstrate the proliferative phase of the cell cycle.